Evaluating the effectiveness of opportunistic eye screening model for people with Diabetes attending Diabetes clinic at Mnazi Mmoja hospital, Zanzibar
Open accessAbstract
BACKGROUND: Diabetes and its related microvascular complications like Diabetic retinopathy are showing an alarming rise in developing countries like Zanzibar. Objective of the present study is to evaluate the impact of integrating eye screening for all subjects attending the diabetes clinic at Mnazi Mmoja Hospital in Zanzibar and to estimate the prevalence of visual impairment and diabetic retinopathy among the subjects. METHODS: This is a cross sectional study involving 356 randomly selected patients who had attended the diabetes clinic between July and August 2012. All subjects underwent comprehensive eye examination including fundus evaluation after dilatation by a cataract surgeon and an ophthalmologist, independently. Data was collected using the designated questionnaire and analysed using the SPSS software. Blindness and visual impairment was defined as presenting VA <3/60 and <6/18 to 6/60 in the better eye respectively and DR was graded using the International classification of Diabetic Retinopathy severity grading scale. RESULTS: A total of 356/967 subjects were recruited in a duration of 2 months; 176 (49.4%) were male and the mean age was 52.21 (SD 15.3). Targeted eye screening of diabetics showed that 231/356 (65%) of the subjects had eye problems, including potentially blinding conditions that required immediate intervention in contrast to the existing self reported referral where only 10% of an average of 200 diabetics underwent eye checkup in a year. The prevalence of visual impairment was 20.2%; 95% CI: 16.4-24.7 and blindness in 9.3%; 95% CI: 6.7 -12.7. The prevalence of DR was 28.3% and sight-threatening DR was reported in 9%. Among the DR cases, 30% had sight threatening DR including 28% macular edema, 2% severe NPDR and PDR. Multivariate analysis showed a higher risk for any DR in older subjects >50 years (OR: 2.19; 95% CI: 1.14 - 4.25) and in females (OR: 1.92; 95% CI: 1.07 - 3.44). CONCLUSION: Opportunistic DR screening model achieved higher yield of identification of visual impairment and DR compared to the yield of 10% of existing self reported Diabetic eye screening model at Zanzibar. Integration of eye screening at diabetes clinics helps in early identification and provision of appropriate treatment for reducing blindness due to diabetes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sight-threatening diabetic retinopathy is most commonly defined as severe non-proliferative DR, proliferative DR, or clinically significant macular edema.
“Sight-threatening diabetic retinopathy (STDR) is most commonly defined as severe non-proliferative DR (NPDR), proliferative DR (PDR), or clinically significant macular edema (CSME) [8, 10, 11, 13, 14, 21, 33]”
From Diabetic retinopathy screening model in low and middle-income countries: a scoping review (2025) · cites this paper as [13]
The Methods section defines sight-threatening retinopathy as severe NPDR, PDR, or macular edema. It does not specify clinically significant macular edema or establish that this is the most common definition, so the cited paper supports the categories only at a broader level. (LLM, conf=0.87)
Experimental — accuracy not yet measuredImage acquisition was often performed by trained non-physician staff, while final grading was typically carried out by ophthalmologists or retinal specialists in 22 out of 30 studies.
“Image acquisition was often performed by trained non-physician staff (technicians, optometrists, nurses, paramedics), while final grading was typically carried out by ophthalmologists or retinal specialists (22/30 studies) [8–13, 15, 16, 18, 21, 22, 24, 26, 27, 30–37]”
From Diabetic retinopathy screening model in low and middle-income countries: a scoping review (2025) · cites this paper as [13]
The Methods describe examinations by a non-ophthalmologist cataract surgeon and an ophthalmologist, and the Discussion says the ophthalmologist’s assessment was the gold standard for diabetic-retinopathy grading. But this study used indirect ophthalmoscopy rather than image acquisition; the Discussion says fundus photography would have been ideal. As a single study, it also does not establish the cited 22-of-30 count. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe International Clinical Diabetic Retinopathy severity scale was the most commonly utilized severity scale, used in 15 out of 30 studies.
“Various severity scales are used to classify diabetic retinopathy (DR), with the International Clinical Diabetic Retinopathy (ICDR) severity scale being the most commonly utilized in 15 out of 30 studies [9, 11–13, 15, 18, 21–23, 32, 34–36].”
From Diabetic retinopathy screening model in low and middle-income countries: a scoping review (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,267 · see citing works
Lang, G. E., Vaiser, A., Snyder, W. B., & Lynn, J. R. (1974) · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works
Wilkinson, C. P., Ferris, F. L., Klein, R., Lee, P. P., Agardh, C., Davis, M., Dills, D. G., Kampik, A., Pararajasegaram, R., & Verdaguer, J. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,786 · see citing works
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288 · see citing works
Hall, V. J., Thomsen, R. W., Henriksen, O., & Lohse, N. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-564 · Cited by 631 · see citing works
Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
Ding, J., & Wong, T. Y. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0283-6 · Cited by 445 · see citing works
Open-angle Glaucoma and Diabetes
Mitchell, P., Smith, W. T., Chey, T., & Healey, P. R. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30247-4 · Cited by 406 · see citing works
Obesity in women from developing countries
Martorell, R., Khan, L. K., Hughes, M., & Grummer-Strawn, L. M. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600931 · Cited by 383 · see citing works
(1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100010038019 · Cited by 325 · see citing works
Aspray, T. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90216-5 · Cited by 207 · see citing works
Diabetes in Sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia
Azevedo, M., & Alla, S. (2008) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.45268 · Cited by 174 · see citing works
McLarty, D. G., Pollitt, C., & Swai, A. B. M. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01470.x · Cited by 151 · see citing works
Ellis, J. D. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.11.1218 · Cited by 115 · see citing works
Diabetes Microvascular and Macrovascular Disease in Africa
Mbanya, J. C., & Sobngwi, E. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000204 · Cited by 107 · see citing works
Modifiable risk factors for Type 2 diabetes mellitus in a peri‐urban community in South Africa
Levitt, N. S., Steyn, K., Lambert, E. V., Reagon, G., Lombard, C. J., Fourie, J. M., Rossouw, K., & Hoffman, M. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00185.x · Cited by 99 · see citing works
Gibbins, R. L., Owens, D. R., Allen, J. C., & Eastman, L. (1998) · Diabetologia · doi:10.1007/s001250050867 · Cited by 95 · see citing works
Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa
Mbanya, J. C., & Sobngwi, E. (2003) · PubMed · doi:10.25405/ncl.34262052 · Cited by 77 · see citing works
Screening for and managing diabetic retinopathy: Current approaches
Bloomgarden, Z. T. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070331 · Cited by 72 · see citing works
Glover, S. J., Burgess, P. I., Cohen, D. B., Harding, S. P., Hofland, H. W. C., Zijlstra, E. E., & Allain, T. J. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.196071 · Cited by 60 · see citing works
Cataracts associated with systemic disorders and syndromes
Negahban, K., & Chern, K. C. (2002) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200212000-00013 · Cited by 46 · see citing works
Lövestam-Adrian (1997) · Research Portal (Queen's University Belfast) · doi:10.1002/(sici)1096-9136(199712)14:12 · Cited by 4 · see citing works
Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa
Mbanya, J., & Sobngwi, E. (2003) · Journal of cardiovascular risk · doi:10.1097/01.hjr.0000060842.48106.78
Flagged first, then by citations
1 of the 26 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Aliahmad, B., Kumar, D., Sarossy, M., & Jain, R. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-152 · Cited by 32 · see citing works
Training of nonophthalmologists in diabetic retinopathy screening
Rani, P. K., Takkar, B., & Das, T. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1117_21 · Cited by 20 · see citing works
Self-citationAchigbu, E. O., Onyia, O., Oguego, N. C., & Murphy, A. (2023) · Eye · doi:10.1038/s41433-023-02673-y · Cited by 14 · see citing works
Diabetic retinopathy screening model in low and middle-income countries: a scoping review
Lestari, Y. D., Sitompul, R., Widyahening, I. S., Tahapary, D. L., Yusuf, P. A., Sasongko, M. B., Riono, P., Nursakina, Y., & Alexandra, G. (2025) · BMC Public Health · doi:10.1186/s12889-025-25543-6 · Cited by 11 · see citing works
Weerasinghe, L. S., Dunn, H., Fung, A. T.-C., MABERLY, G. F., Cheung, N. W., Weerasinghe, D. P., Liew, G., Do, H., Hng, T., Pryke, A., et al. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003376 · Cited by 10 · see citing works
Rani, P. K., Kalavalapalli, D. B., Narayanan, R., Kalavalapalli, S., Narula, R., Sahay, R. K., & Deo, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324382 · Cited by 2 · see citing works
Self-citationAjaz, A., Kumar, H., Aliahmad, B., & Kumar, D. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.100248 · Cited by 1 · see citing works
Factor Influencing Decision for Eye Screening among Diabetes Patients: A Review
Sumaiyah Jamaludin, T. S. (2020) · Nursing & Healthcare International Journal · doi:10.23880/nhij-16000215 · Cited by 1 · see citing works
- Authors
- Omar, F. J., Sheeladevi, S., Rani, P. K., Ning, G., & Kabona, G.
- Affiliations
- L V Prasad Eye Institute (IN)
- Corresponding author
- Rani, Padmaja Kumari
- Venue
- BMC Ophthalmology
- Published
- 2014-06-24
- Volume
- 14
- Issue
- 1
- Pages
- 81-81
- ISSN
- 1471-2415 (ISSN-L)
- PMC
- PMC4078096
- OpenAlex
- W2001143438
- Cited by
- 8
- References
- 26
- Citations by year
- 2025: 2 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2014: 1
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Ophthalmology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Epidemiology › Ophthalmology and Visual Impairment Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, diabetes clinic, visual impairment, blindness, diabetic macular edema, prevalence, screening effectiveness, risk factors, Zanzibar, access to eye care, fundus examination, dilated eye examination, sex differences, diabetic microvascular complications
- MeSH terms
- Adolescent, Adult, Blindness, Child, Cross-Sectional Studies, Diabetes Mellitus, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Ophthalmoscopy, Retrospective Studies, Severity of Illness Index, Tanzania, Visual Acuity, Reproducibility of Results, Incidence, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review